Reappraisal of kanamycin usage in neonates

Jorge B. Howard, George H. McCracken

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

This study documents an important change in the kanamycin susceptibilities of Escherichia coli strains cultivated from neonates. Whereas some nurseries have in the past experienced resistance rates as high as 70%, recent surveillance of seven North American nurseries demonstrated that 90% or more of E. coli strains are currently susceptible to kanamycin. Pharmacokinetic studies of 65 babies treated with either 7.5 or 10 mg/kg kanamycin doses revealed that peak serum values varied with dosage, birthweight, and chronologic age. Peak serum levels were below the desired therapeutic range in many babies treated with 7.5 mg/kg doses of kanamycin every 12 hours. Concentrations in cerebrospinal fluid specimens from 21 infants were 0.5 to 12 μg/ml after 7.5 mg/kg kanamycin doses. Calculated distribution volumes, plasma clearances, and serum halflife values were used in formulating a revised kanamycin dosage and frequency of administration schedule.

Original languageEnglish (US)
Pages (from-to)949-956
Number of pages8
JournalThe Journal of Pediatrics
Volume86
Issue number6
DOIs
StatePublished - 1975

Fingerprint

Kanamycin
Newborn Infant
Nurseries
Serum
Escherichia coli
Plasma Volume
Half-Life
Cerebrospinal Fluid
Appointments and Schedules
Pharmacokinetics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Reappraisal of kanamycin usage in neonates. / Howard, Jorge B.; McCracken, George H.

In: The Journal of Pediatrics, Vol. 86, No. 6, 1975, p. 949-956.

Research output: Contribution to journalArticle

Howard, Jorge B. ; McCracken, George H. / Reappraisal of kanamycin usage in neonates. In: The Journal of Pediatrics. 1975 ; Vol. 86, No. 6. pp. 949-956.
@article{af39dd9ee1084d068bec859300874322,
title = "Reappraisal of kanamycin usage in neonates",
abstract = "This study documents an important change in the kanamycin susceptibilities of Escherichia coli strains cultivated from neonates. Whereas some nurseries have in the past experienced resistance rates as high as 70{\%}, recent surveillance of seven North American nurseries demonstrated that 90{\%} or more of E. coli strains are currently susceptible to kanamycin. Pharmacokinetic studies of 65 babies treated with either 7.5 or 10 mg/kg kanamycin doses revealed that peak serum values varied with dosage, birthweight, and chronologic age. Peak serum levels were below the desired therapeutic range in many babies treated with 7.5 mg/kg doses of kanamycin every 12 hours. Concentrations in cerebrospinal fluid specimens from 21 infants were 0.5 to 12 μg/ml after 7.5 mg/kg kanamycin doses. Calculated distribution volumes, plasma clearances, and serum halflife values were used in formulating a revised kanamycin dosage and frequency of administration schedule.",
author = "Howard, {Jorge B.} and McCracken, {George H.}",
year = "1975",
doi = "10.1016/S0022-3476(75)80234-4",
language = "English (US)",
volume = "86",
pages = "949--956",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Reappraisal of kanamycin usage in neonates

AU - Howard, Jorge B.

AU - McCracken, George H.

PY - 1975

Y1 - 1975

N2 - This study documents an important change in the kanamycin susceptibilities of Escherichia coli strains cultivated from neonates. Whereas some nurseries have in the past experienced resistance rates as high as 70%, recent surveillance of seven North American nurseries demonstrated that 90% or more of E. coli strains are currently susceptible to kanamycin. Pharmacokinetic studies of 65 babies treated with either 7.5 or 10 mg/kg kanamycin doses revealed that peak serum values varied with dosage, birthweight, and chronologic age. Peak serum levels were below the desired therapeutic range in many babies treated with 7.5 mg/kg doses of kanamycin every 12 hours. Concentrations in cerebrospinal fluid specimens from 21 infants were 0.5 to 12 μg/ml after 7.5 mg/kg kanamycin doses. Calculated distribution volumes, plasma clearances, and serum halflife values were used in formulating a revised kanamycin dosage and frequency of administration schedule.

AB - This study documents an important change in the kanamycin susceptibilities of Escherichia coli strains cultivated from neonates. Whereas some nurseries have in the past experienced resistance rates as high as 70%, recent surveillance of seven North American nurseries demonstrated that 90% or more of E. coli strains are currently susceptible to kanamycin. Pharmacokinetic studies of 65 babies treated with either 7.5 or 10 mg/kg kanamycin doses revealed that peak serum values varied with dosage, birthweight, and chronologic age. Peak serum levels were below the desired therapeutic range in many babies treated with 7.5 mg/kg doses of kanamycin every 12 hours. Concentrations in cerebrospinal fluid specimens from 21 infants were 0.5 to 12 μg/ml after 7.5 mg/kg kanamycin doses. Calculated distribution volumes, plasma clearances, and serum halflife values were used in formulating a revised kanamycin dosage and frequency of administration schedule.

UR - http://www.scopus.com/inward/record.url?scp=0016806047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016806047&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(75)80234-4

DO - 10.1016/S0022-3476(75)80234-4

M3 - Article

VL - 86

SP - 949

EP - 956

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -